To determine whether iRGD-Exo-BCL6 siRNA1 could suppress DLBCL cell proliferation, OCI-Ly8 cells were treated with blank-Exo-BCL6 siRNA1 and iRGD-Exo-BCL6 siRNA for 24 h. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.